Journal of the Society for Gynecologic Investigation

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

http://mc.manuscriptcentral.com/rsci

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malamitsi-Puchner, A.
Right arrow Articles by Hassiakos, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malamitsi-Puchner, A.
Right arrow Articles by Boutsikou, T.
Right arrow Articles by Economou, E.
Right arrow Articles by Makrakis, E.
Right arrow Articles by Iliodromiti, Z.
Right arrow Articles by Kouskouni, E.
Right arrow Articles by Hassiakos, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of the Society for Gynecologic Investigation, Vol. 12, No. 3, 195-197 (2005)
DOI: 10.1016/j.jsgi.2005.01.006

The Role of the Anti-Angiogenic Factor Endostatin in Intrauterine Growth Restriction

Ariadne Malamitsi-Puchner, MD

Neonatal Division, 2nd Department of Obstetrics and Gynecology, University of Athens, 19, Soultani Str., GR-10682 Athens, Greece; malamitsi{at}aias.gr

Theodora Boutsikou, MD

Emmanuel Economou, PhD

Evangelos Makrakis, MD

Zoe Iliodromiti, MD

Evangelia Kouskouni, MD

Demetrios Hassiakos, MD

2nd Department of Obstetrics and Gynecology, University of Athens, Athens, Greece

Objective: To study the impact of intrauterine growth restriction (IUGR) on anti-angiogenesis, by determining and comparing circulating levels of the potent anti-angiogenic factor endostatin, in full-term IUGR (under the 10th customized centile) and appropriate for gestational age (AGA)fetuses, neonates, as well as their mothers, granted that IUGR implies hypoxia and endostatin is down-regulated by the latter.

Methods: In 20 IUGR cases (mainly due to hypertension or preeclampsia) and 20 AGA controls we detenmined circulating endostatin levels, by enzyme immunoassay in the serum of mothers (MS), umbilical cords (UC-mixed arteriovenous blood)-representing the fetal state, and asymptomatic neonates on day 1 (N1) and 4 (N4) of lfe-signifying transition and stabilization to extrauterine life, respectively.

Results: Endostatin levels were significantly higher in AGA than IUGR UC, N1, and N4 (P <. 0000, P = .0006, P = .024, respectively). Furthermore, UC endostatin levels positively correlated with the customized centiles of the infants (Spearman correlation coefficient 0. 69, P = .00001).

Conclusions: IUGR is characterized by lower circulating endostatin concentrations in the fetus and neonate, possibly because under lower oxygen concentrations an unbalanced state of angiogenesis stimulators versus inhibitors takes place.

Key Words: Endostatin • intrauterine growth restriction • preeclampsia • intrauterine hypoxia • angiogenesis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?